Clinical Trials in Pennsylvania

Showing 3921-3940 of 19,675 trials

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

NCT02675465

This is an international, multi-center, open-label study designed to evaluate if the co-administration of investigational new drugs ATB200 and AT2221 is safe in adults with Pompe disease.

Pompe Disease

Amicus Therapeutics29 participantsStarted Apr 2016

Phoenix, Arizona, United States • Orange, California, United States • Gainesville, Florida, United States +16 more locations

TERMINATEDPhase 195 miles

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

NCT04543188

First-in-human study to assess safety, tolerability, PK, and preliminary activity of PF-07284890 as a single agent and in combination with binimetinib in participants with BRAF V600-mutated advanced solid tumor malignancies with and without brain involvement.

Malignant MelanomaCarcinoma, Non-Small-Cell LungBrain Neoplasms, Primary+2 more

Pfizer65 participantsStarted Jan 2021

Duarte, California, United States • San Francisco, California, United States • Orlando, Florida, United States +42 more locations

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Find Trials by Condition in Pennsylvania

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

The Myelin Disorders Biorepository Project

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Survey Study on Barrett's Esophagus Screening

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Minima Stent System Post- Approval Study (PAS)

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Non-Operative Management and Early Response Assessment in Rectal Cancer

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors